Of the tracked stories, 1 of 2 also mention Assisted-dying bill, the most common co-covered peer. Across a 48-day span, the pace is roughly 0.3 stories per week. Each story carries 3 original sources on average, compared with 4.7 for the broader beat in this window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Emmanuel Macron
Of the tracked stories, 1 of 2 also mention Assisted-dying bill, the most common co-covered peer. Across a 48-day span, the pace is roughly 0.3 stories per week. Each story carries 3 original sources on average, compared with 4.7 for the broader beat in this window. The clearest coverage concentration is funding: 1 of 2 stories, with the rest divided among 1 other category. The 6 average consequence score is below the beat benchmark of 6.5 in the same window. We currently track 2 Biotech stories that mention Emmanuel Macron, published between June 15, 2026 and August 1, 2026.
Stories tracked
2
Per week
0.3
Sources per story
3
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 177 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Emmanuel Macron. Shared-story counts are live from our verified record — not editorial picks.
France's historic vote to legalize assisted dying creates a new regulatory landscape for pharmaceutical companies developing end-of-life drugs. With 300 million people globally already having access, the French market offers opportunities for drug manufacturers, biotech firms, and palliative medicine innovators. Constitutional review awaits, but the pharma sector must prepare for evolving demand.
Biotechnology and healthcare are key sectors at Bharat Innovates 2026, where 120 Indian startups seek to attract global investment and forge R&D partnerships.
Emmanuel Macron is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.
